Quick Answer
New York runs one of the most comprehensive opioid treatment systems in the country through OASAS, the Office of Addiction Services and Supports, with Medicaid covering all three FDA-approved medications and hundreds of certified programs statewide. New York also recorded one of the nation's steepest overdose declines, with CDC provisional data showing deaths falling more than 25 percent in 2025. Start with the OASAS HOPEline, the SAMHSA National Helpline at 1-800-662-4357, or FindTreatment.gov.
New York is currently one of the most encouraging stories in American overdose data. CDC provisional figures for 2025 place it among the states with declines of 25 percent or more, one of the sharpest drops in the country, against a national backdrop of an estimated 69,973 overdose deaths in 2025, down almost 14 percent from 2024. The decline did not happen by accident; it tracks years of aggressive naloxone saturation, expanded medication access, and a treatment system that is unusually centralized and navigable.
How New York Organizes Opioid Treatment
Nearly everything in New York addiction care runs through OASAS, the Office of Addiction Services and Supports, which certifies programs, funds treatment, and operates the state's treatment availability dashboard. If a program treats addiction in New York, OASAS certifies it, which makes verifying legitimacy far easier than in most states.
The system includes:
- Methadone through one of the largest networks of certified opioid treatment programs in the nation, concentrated in New York City but present upstate as well; program mechanics are explained in our medications guide.
- Buprenorphine (Suboxone) through OASAS clinics, office-based prescribers, telehealth, and a growing number of emergency departments that begin medication on the spot.
- Naltrexone and Vivitrol for patients who complete withdrawal first, an option weighed against the agonist medications in our medication comparison.
- Withdrawal management at every level from outpatient to hospital-based care, with placement guided by ASAM Criteria style assessment; the tradeoffs are covered in inpatient vs outpatient and the detox education resources at getdetox.com.
New York also operates the HOPEline, a state helpline offering confidential referrals around the clock, alongside the federal SAMHSA line. Between OASAS's provider search, the HOPEline, and FindTreatment.gov, New Yorkers have three reliable routes to a verified program.
Paying for Treatment in New York
New York expanded Medicaid, and New York Medicaid covers methadone, buprenorphine, naltrexone, counseling, inpatient rehabilitation, and residential treatment when medically necessary. The state's Essential Plan extends low-cost coverage above Medicaid income limits, and commercial plans must cover substance use disorder treatment under state parity laws that New York enforces actively. Uninsured New Yorkers can access OASAS-funded programs at reduced or no cost. The general playbook for verifying benefits is in paying for treatment.
What Is Driving the Decline, and What Still Kills
Naloxone is everywhere in New York, in pharmacies without individual prescriptions, in libraries, in transit hubs, and that saturation is widely credited with a large share of the decline. What still kills is fentanyl, often combined with the veterinary sedative xylazine, which does not respond to naloxone and complicates overdose response. The educational overview of fentanyl and its adulterants at opiates.org covers what makes today's supply categorically more dangerous than the heroin era. The practical takeaway is unchanged: carry naloxone, never use alone, and treat any unexpected sedation as an emergency.
Whatever entry point you choose, remember the system's own framing: withdrawal management is a beginning, not a treatment. The full arc, assessment through ongoing care, is described in what to expect in treatment.
New York Statistics Snapshot
| Measure | Figure | Source |
|---|---|---|
| U.S. overdose deaths, 2025 (provisional) | 69,973, down almost 14% from 2024 | CDC/NCHS |
| New York's 2025 decline | More than 25 percent, among the nation's steepest | CDC/NCHS |
| Dominant fatal substance | Illicit fentanyl, increasingly with xylazine | CDC |
| Treatment system | Hundreds of OASAS-certified programs statewide | OASAS |
A note on reading New York data: the CDC reports New York City and the rest of the state separately in some provisional datasets, so statewide figures depend on which series is quoted. The direction is unambiguous in both series, and the decline is the relevant headline.
Special Situations: Pregnancy, Justice Involvement, and Veterans
Pregnancy. Opioid use disorder during pregnancy is treated, not punished, in the medical system: methadone and buprenorphine are the standard of care during pregnancy because untreated withdrawal endangers the fetus, and abrupt detoxification is generally not recommended. Pregnant patients receive priority admission at federally funded programs nationwide, including in New York, so disclosing pregnancy when calling moves you up the list rather than down.
Justice involvement. Courts, jails, and reentry programs in New York increasingly permit or provide medications for opioid use disorder, and federal disability law has been used to challenge blanket bans on agonist medication. If you are entering or leaving a correctional setting, ask specifically about medication continuation; the days immediately after release carry some of the highest overdose risk anywhere in the data, because tolerance falls during incarceration.
Veterans. The VA covers all three medications for opioid use disorder and related care, and veterans in New York can access treatment through VA medical centers and community care networks even when other coverage is unavailable. New York's Medicaid expansion and Essential Plan give most low-income veterans overlapping coverage routes beyond the VA itself.
Frequently Asked Questions
What is OASAS and why does it matter?
OASAS, New York's Office of Addiction Services and Supports, certifies and funds nearly all addiction treatment in the state. Its certification requirement means any legitimate New York program appears in OASAS systems, which gives New Yorkers an unusually reliable way to verify providers before committing.
What is the New York HOPEline?
The HOPEline is New York State's free, confidential, 24/7 helpline for addiction and problem gambling, staffed to provide referrals to OASAS-certified treatment. It operates alongside the federal SAMHSA National Helpline at 1-800-662-4357; either can connect you to care.
Does New York Medicaid cover methadone and Suboxone?
Yes. New York Medicaid covers methadone through certified opioid treatment programs, buprenorphine through clinics and office-based prescribers, naltrexone, counseling, and higher levels of care when medically necessary. New York expanded Medicaid, so income-eligible adults qualify regardless of parental status.
Why did New York's overdose deaths drop so sharply?
CDC provisional data show New York among the states with declines above 25 percent in 2025. Public health officials point to naloxone saturation, expanded access to methadone and buprenorphine, fentanyl test strip distribution, and post-overdose outreach programs, though researchers are still separating the contributing causes.
Can I start buprenorphine in a New York emergency room?
Many New York hospitals now begin buprenorphine in the emergency department after an overdose or during withdrawal and link patients to follow-up care. Asking the ER directly whether they offer buprenorphine induction is appropriate and increasingly answered yes.
Where are methadone clinics in New York located?
New York operates one of the country's largest networks of certified opioid treatment programs, with the heaviest concentration in New York City and programs in most upstate metropolitan areas. FindTreatment.gov and OASAS provider searches both list certified locations.
What is xylazine and why does it matter in New York?
Xylazine is a veterinary sedative increasingly mixed into fentanyl in the Northeast. It deepens sedation, causes severe wounds with repeated use, and does not respond to naloxone, though naloxone should still be given in any suspected overdose because fentanyl is almost always present too.
Need Help Now?
These free, confidential resources are available anytime. No commitment required.
About the Reviewer
Clare Waismann, M-RAS, SUDCC II, is a Registered Addiction Specialist and Substance Use Disorder Certified Counselor II, and the founder of the Waismann Method. Her reviews focus on accuracy, compassion, and stigma-free language within her scope of addiction counseling and recovery advocacy. Clare is not a physician; her reviews do not constitute medical advice, diagnosis, or treatment.